Table 4.
Most Recent Cardiac Evaluation by Sample | Revascularization Procedures after Evaluationa
|
No. of CE per Revascularizationb | ||
---|---|---|---|---|
Angioplasty and/or Stent Deployment [no. (%)] | Coronary Artery Bypass Grafting [no. (%)] | Any Revascularization [no. (%)] | ||
CE of any form | ||||
full cohort (n = 12,876) | 705 (5.5) | 557 (4.3) | 1228 (9.5) | 10.5 |
high risk (n = 10,482) | 701 (6.7) | 554 (5.3) | 1221 (11.6) | 8.6 |
lower risk (n = 2394) | 4 (0.2) | 3 (0.1) | 7 (0.3) | 342.0 |
Noninvasive Stress Test | ||||
full cohort (n = 11,341) | 254 (2.2) | 174 (1.5) | 411 (3.6) | 27.6 |
high risk (n = 9120) | 251 (2.7) | 173 (1.9) | 407 (4.5) | 22.4 |
lower risk (n = 2221) | 3 (0.1) | 1 (0.1) | 4 (0.2) | 555.3 |
Coronary angiography | ||||
full cohort (n = 5385) | 667 (12.4) | 531 (9.9) | 1172 (21.8) | 4.6 |
high risk (n = 4957) | 664 (13.4) | 529 (10.7) | 1167 (23.5) | 4.2 |
lower risk (n = 428) | 3 (0.7) | 2 (0.5) | 5 (1.2) | 85.6 |
Interventions performed between the dates of last pretransplant cardiac evaluation and transplantation. In patients evaluated by both angiography after noninvasive testing, the revascularization is scored as following the most recent evaluation test.
No. of cardiac evaluations of the indicated type performed per pretransplant coronary revascularization procedure (angioplasty or bypass grafting) in the specified cohort. Computations were based on the most recent CE before transplant and subsequent pretransplant revascularization status (any versus none) per individual.